-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.00181.69% Upside
TScan Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover TScan Therapeutics, Inc.?
TScan Therapeutics, Inc. has been rated by research analysts at BTIG in the past 90 days.